Patents by Inventor Joseph Sulner

Joseph Sulner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
    Patent number: 11013692
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Types of surface properties that are altered by the disclosed methods include electrostatic properties, hydrophobic properties, and hydrogen bonding properties.
    Type: Grant
    Filed: June 12, 2019
    Date of Patent: May 25, 2021
    Assignee: MannKind Corporation
    Inventors: Keith A. Oberg, Joseph Sulner, Marshall L. Grant
  • METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES FOR ACTIVE AGENTS
    Publication number: 20190290586
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Types of surface properties that are altered by the disclosed methods include electrostatic properties, hydrophobic properties, and hydrogen bonding properties.
    Type: Application
    Filed: June 12, 2019
    Publication date: September 26, 2019
    Inventors: Keith A. Oberg, Joseph Sulner, Marshall L. Grant
  • Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
    Patent number: 10357459
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Types of surface properties that are altered by the disclosed methods include electrostatic properties, hydrophobic properties, and hydrogen bonding properties.
    Type: Grant
    Filed: June 21, 2017
    Date of Patent: July 23, 2019
    Assignee: MannKind Corporation
    Inventors: Keith A. Oberg, Joseph Sulner, Marshall L. Grant
  • METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES FOR ACTIVE AGENTS
    Publication number: 20170281549
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Types of surface properties that are altered by the disclosed methods include electrostatic properties, hydrophobic properties, and hydrogen bonding properties.
    Type: Application
    Filed: June 21, 2017
    Publication date: October 5, 2017
    Inventors: Keith A. Oberg, Joseph Sulner, Marshall L. Grant
  • Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
    Patent number: 9717689
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Types of surface properties that are altered by the disclosed methods include electrostatic properties, hydrophobic properties, and hydrogen bonding properties.
    Type: Grant
    Filed: February 5, 2016
    Date of Patent: August 1, 2017
    Assignee: MannKind Corporation
    Inventors: Keith A. Oberg, Joseph Sulner, Marshall L. Grant
  • METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES FOR ACTIVE AGENTS
    Publication number: 20160151287
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Types of surface properties that are altered by the disclosed methods include electrostatic properties, hydrophobic properties, and hydrogen bonding properties.
    Type: Application
    Filed: February 5, 2016
    Publication date: June 2, 2016
    Inventors: Keith A. Oberg, Joseph Sulner, Marshall L. Grant
  • Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
    Patent number: 9283193
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Type of surface properties that are altered by the disclosed methods include by electrostatic properties, hydrophobic properties and hydrogen bonding properties.
    Type: Grant
    Filed: April 10, 2014
    Date of Patent: March 15, 2016
    Assignee: MannKind Corporation
    Inventors: Keith A. Oberg, Joseph Sulner, Marshall L. Grant
  • METHOD OF DRUG FORMULATION BASED ON INCREASING THE AFFINITY OF CRYSTALLINE MICROPARTICLE SURFACES FOR ACTIVE AGENTS
    Publication number: 20140308358
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Type of surface properties that are altered by the disclosed methods include by electrostatic properties, hydrophobic properties and hydrogen bonding properties.
    Type: Application
    Filed: April 10, 2014
    Publication date: October 16, 2014
    Applicant: MannKind Corporation
    Inventors: Keith A. Oberg, Joseph Sulner
  • Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
    Patent number: 8729019
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Type of surface properties that are altered by the disclosed methods include by electrostatic properties, hydrophobic properties and hydrogen bonding properties.
    Type: Grant
    Filed: July 6, 2010
    Date of Patent: May 20, 2014
    Assignee: Mannkind Corporation
    Inventors: Keith A. Oberg, Joseph Sulner
  • Method of Drug Formulation Based on Increasing the Affinity of Crystalline Microparticle Surfaces for Active Agents
    Publication number: 20100278924
    Abstract: Methods are provided for coating crystalline microparticles with an active agent by altering the surface properties of the microparticles in order to facilitate favorable association on the microparticle by the active agent. Type of surface properties that are altered by the disclosed methods include by electrostatic properties, hydrophobic properties and hydrogen bonding properties.
    Type: Application
    Filed: July 6, 2010
    Publication date: November 4, 2010
    Applicant: MANNKIND CORPORATION
    Inventors: Keith A. Oberg, Joseph Sulner
  • Repair of tympanic membrane using placenta derived collagen biofabric
    Publication number: 20070038298
    Abstract: The present invention provides a method of repairing a tympanic membrane deformity, such as a tympanic membrane perforation, commonly referred to as tympanoplasty or myringoplasty, using a collagen biofabric. The collagen biofabric is preferably laminated. The invention further provides kits comprising one or more pieces of collagen biofabric, for example laminated collagen biofabric, for the repair of a tympanic membrane.
    Type: Application
    Filed: June 29, 2006
    Publication date: February 15, 2007
    Inventors: Joseph Sulner, Janice Smiell, Sharon Bourke, Patricia Murphy
  • Potentiation of glucose elimination
    Publication number: 20070020191
    Abstract: Methods related to the treatment of diabetes and improving the efficiency of insulin utilization are provided. The method enables effective control of prandial glucose levels while reducing the risk of postprandial hypoglycemia. In particular, methods of potentiating the activity of endogenous insulin in type 2 diabetics and exogenous long-acting insulin in diabetics requiring basal insulin replacement are provided.
    Type: Application
    Filed: January 10, 2006
    Publication date: January 25, 2007
    Applicant: MannKind Corporation
    Inventors: Anders Boss, Solomon Steiner, Rodney Woods, Joseph Sulner